VAERS reports by lot

GSK Varicella/Shingles lot 22M3K: VAERS reports

31 VAERS reports list lot 22M3K as a GSK Varicella/Shingles vaccine, received between 2023-05-21 and 2024-12-09. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
31
Reports
3%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1726%
Injection-site / Local reaction1218%
Musculoskeletal914%
Neurological711%
Dermatological (non-injection-site)711%
Gastrointestinal58%
Cardiac / Cardiovascular35%
Allergic / Anaphylactic35%
Respiratory35%

Where reports came from

U.S. state of the reporter, where given (top 12).

Illinois5
Texas3
Florida3
Louisiana3
California2
Arizona2
Georgia2
Minnesota1
Tennessee1
North Carolina1
Missouri1
Colorado1

Reports by month received

2023-058
2023-069
2023-075
2023-081
2023-092
2023-102
2024-032
2024-081
2024-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.